GLP-1 RAs Hold Promising Potential for Reduction of Cardiometabolic Risk Factors additional benefits : Brain: Appetite suppression, nerve protection, and decreased neuroinflammation Heart: Decreased blood pressure (systolic and diastolic), reduced total cholesterol levels, lowered endothelial dysfunction, and increased heart rate Liver: Decreased glucose production Pancreas: Increased insulin secretion, decreased glucagon secretion, B islet cell proliferation GI Tract: Decreased gastric emptying Because these drugs cause weight loss, it is not clear whether the GLP-1 RAs or the weight loss reduces cardiometabolic risks
One major factor for success is managing side effects, particularly gastrointestinal issues
10.1111/j.1432-1033.1993.tb17986.x 19
Services & Pricing* 100% absorption Most IVs take 4560 min Medically supervised HSA & FSA eligible *Prices vary by location IV therapy in Dallas, TX delivers nutrients directly into the bloodstream for efficient nutrient delivery
A systematic search of PubMed, EMBASE, Cochrane Library, and Web of Science, Google Scholar was conducted up to September 2024
[12] [1] Scientific References Ozempic EPAR Product Information
